These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 11668194)

  • 1. Trafficking of surface-linked and encapsulated liposomal antigens in macrophages: an immunocytochemical study.
    Fortin A; Lagacé J; Thérien HM
    J Histochem Cytochem; 2001 Nov; 49(11):1407-20. PubMed ID: 11668194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between in vitro and in vivo behaviour of liposomal antigens.
    Shahum E; Thérien HM
    Vaccine; 1994 Sep; 12(12):1125-31. PubMed ID: 7998423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteasome inhibitors block the entry of liposome-encapsulated antigens into the classical MHC class I pathway.
    Rothwell SW; Wassef NM; Alving CR; Rao M
    Immunol Lett; 2000 Oct; 74(2):141-52. PubMed ID: 10996390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trafficking of liposomal antigen to the trans-Golgi of murine macrophages requires both liposomal lipid and liposomal protein.
    Rao M; Rothwell SW; Wassef NM; Koolwal AB; Alving CR
    Exp Cell Res; 1999 Jan; 246(1):203-11. PubMed ID: 9882529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential activation of cell-mediated immune functions by encapsulated and surface-linked liposomal antigens.
    Fortin A; Shahum E; Krzystyniak K; Thérien HM
    Cell Immunol; 1996 May; 169(2):208-17. PubMed ID: 8620548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The intrasplenic circulation of three formulations of the same protein antigen.
    Davis M; Fortin A; Thérien HM
    Immunobiology; 2002 Jul; 205(3):204-18. PubMed ID: 12182449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic macrophages: liposomes bearing antigen, class II MHC and membrane-IL-1.
    Bakouche O; Lachman LB
    Lymphokine Res; 1990; 9(3):259-81. PubMed ID: 2398741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomal adjuvanticity: effect of encapsulation and surface-linkage on antibody production and proliferative response.
    Shahum E; Thérien HM
    Int J Immunopharmacol; 1995 Jan; 17(1):9-20. PubMed ID: 7782155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen presentation by liposomes bearing class II MHC and membrane IL-1.
    Bakouche O; Lachman LB
    Yale J Biol Med; 1990; 63(2):95-107. PubMed ID: 2399741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular processing of liposome-encapsulated antigens by macrophages depends upon the antigen.
    Rao M; Wassef NM; Alving CR; Krzych U
    Infect Immun; 1995 Jul; 63(7):2396-402. PubMed ID: 7790049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential biodistribution of encapsulated and surface-linked liposomal antigens.
    Thérien HM; Shahum E
    Biochim Biophys Acta; 1996 Apr; 1280(1):91-7. PubMed ID: 8634320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomal vaccines: clinical status and immunological presentation for humoral and cellular immunity.
    Alving CR
    Ann N Y Acad Sci; 1995 May; 754():143-52. PubMed ID: 7625648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the mechanisms of defective antigen presentation after hemorrhage.
    Ertel W; Morrison MH; Ayala A; Chaudry IH
    Surgery; 1991 Aug; 110(2):440-5; discussion 445-7. PubMed ID: 1858052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic T lymphocytes induced by liposomal antigens: mechanisms of immunological presentation.
    Alving CR; Wassef NM
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S91-4. PubMed ID: 7532427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phagocytosis of liposomes by macrophages: intracellular fate of liposomal malaria antigen.
    Verma JN; Wassef NM; Wirtz RA; Atkinson CT; Aikawa M; Loomis LD; Alving CR
    Biochim Biophys Acta; 1991 Jul; 1066(2):229-38. PubMed ID: 1854787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phagosomes are fully competent antigen-processing organelles that mediate the formation of peptide:class II MHC complexes.
    Ramachandra L; Song R; Harding CV
    J Immunol; 1999 Mar; 162(6):3263-72. PubMed ID: 10092778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and kinetics of MHC class I-restricted presentation of a soluble antigen delivered by liposomes.
    Zhou F; Watkins SC; Huang L
    Immunobiology; 1994 Feb; 190(1-2):35-52. PubMed ID: 8082886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomal formulations of synthetic MUC1 peptides: effects of encapsulation versus surface display of peptides on immune responses.
    Guan HH; Budzynski W; Koganty RR; Krantz MJ; Reddish MA; Rogers JA; Longenecker BM; Samuel J
    Bioconjug Chem; 1998; 9(4):451-8. PubMed ID: 9667946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenic peptides bind to class II MHC molecules in an early lysosomal compartment.
    Harding CV; Geuze HJ
    J Immunol; 1993 Oct; 151(8):3988-98. PubMed ID: 8409381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.